NCT04552860

Brief Summary

An uncontrolled pilot in which Veterans age 60-95 years with chronic musculoskeletal (MSK) pain will undergo Emotional Awareness and Expression Therapy (EAET) delivered over video teleconference (VTC; together vEAET). This study aims to obtain early implementation outcomes, as well as evaluate efficacy and estimated effect sizes.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
16

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2020

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 15, 2020

Completed
18 days until next milestone

First Submitted

Initial submission to the registry

September 2, 2020

Completed
15 days until next milestone

First Posted

Study publicly available on registry

September 17, 2020

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

August 16, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

August 16, 2021

Completed
Last Updated

April 26, 2024

Status Verified

April 1, 2024

Enrollment Period

1 year

First QC Date

September 2, 2020

Last Update Submit

April 23, 2024

Conditions

Keywords

Chronic PainPsychotherapyMusculoskeletal DiseaseVideo Teleconference Delivered Therapy

Outcome Measures

Primary Outcomes (4)

  • The Satisfaction with Therapy and Therapist Scale-Revised

    Satisfaction with therapy subscale is the summation of six items, each scored 1-5 (1 = maximum dissatisfaction; 5 = maximum satisfaction), yielding a total score between 6 and 30. Satisfaction with therapist subscale is the summation of six items, each scored 1-5 (1 = maximum dissatisfaction; 5 = maximum satisfaction), yielding a total score between 6 and 30. Overall satisfaction is an additional single item scored 1-5 (1 = maximum dissatisfaction; 5 = maximum satisfaction). The two subscales and the overall satisfaction item are each reported separately.

    8-Week Post-treatment

  • Credibility/Expectancy Questionnaire

    Logical Credibility/Expectancy subscale is the average of four self report items, three of which are scored 1-9 (1 = not at all logical; 9 = very logical). A fourth Logical Credibility/Expectancy item reflects the percentage of functioning improvement participants think will occur. Feeling Credibility/Expectancy subscale is the average of four self report items, three of which are scored 1-9 (1 = not at all logical; 9 = very logical). A fourth Feeling Credibility/Expectancy item reflects the percentage of functioning improvement participants feel will occur. The two subscales are each reported separately.

    Baseline

  • Functional Assessment of Currently Employed Technology Scale (FACETS)

    The summation of ten items related to ease of use of technology, each scored 1-6 (1 = never use a technology; 5 = easy/regular use of a technology), yielding a total score between 10 and 60.

    Change from Baseline, 8-Week Post-treatment, 2-Month Follow Up

  • Percent of Group Therapy Sessions Attended

    Number of sessions each participant attends divided by 8 sessions (total number of sessions available to attend).

    8 Weeks

Secondary Outcomes (13)

  • Anger Discomfort Scale

    Change from Baseline, 8-Week Post-treatment, 2-Month Follow Up

  • Brief Pain Inventory (BPI)

    Change from Baseline, 8-Week Post-treatment, 2-Month Follow Up

  • Coping Strategies Questionnaire (CSQ)

    Change from Baseline, 8-Week Post-treatment, 2-Month Follow Up

  • Patient Reported Outcomes Measurement Information System (PROMIS)-Anxiety Short Form 7a

    Change from Baseline, 8-Week Post-treatment, 2-Month Follow Up

  • PROMIS-Depression Short Form 8a

    Change from Baseline, 8-Week Post-treatment, 2-Month Follow Up

  • +8 more secondary outcomes

Study Arms (1)

Emotional Awareness and Expression Therapy

EXPERIMENTAL

Seeks to reduce physical (e.g., pain) and emotional (e.g., depression, anxiety) symptoms by helping individuals become aware of their emotions, express them, and resolve emotional conflicts. It will use techniques such as writing about stress, role playing how to handle difficult relationships, recognizing and expressing anger and other feelings, and being more open with others.

Behavioral: Emotional Awareness and Expression Therapy

Interventions

Focus on emotions, writing about stress, assertiveness training, role playing new ways to handle relationships, and sharing feelings and experiences with others.

Also known as: EAET
Emotional Awareness and Expression Therapy

Eligibility Criteria

Age60 Years - 95 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Eligible Veterans are age 60-95 years old and have had at least 3 months of musculoskeletal pain, including the following conditions most likely to benefit from psychotherapy based on previous research: low back, neck, leg, or pelvic pain; temporomandibular joint disorders; fibromyalgia; tension headaches; or any combination of these disorders.

You may not qualify if:

  • Musculoskeletal conditions likely to respond surgical or pharmacologic treatment: hip or knee osteoarthritis, leg pain greater than back pain (to exclude radiculopathy), electromyography-confirmed "tunnel" syndrome (e.g., carpal tunnel syndrome), gout, neuralgias, migraine, and cluster headaches;
  • Non-musculoskeletal pain conditions: autoimmune disease that typically generates pain (e.g., rheumatoid arthritis), cancer pain, sickle cell disease, burn pain, infection associated with pain, and cauda equina syndrome;
  • The following conditions or circumstances: severe psychiatric disorder such as schizophrenia or bipolar I disorder not controlled with medications, active suicide or violence risk, active severe alcohol or substance use disorder, substantial cognitive impairment based on chart review, previously completed EAET, currently enrolled in another psychological treatment for chronic pain, currently in pain-related litigation or applying for pain-related compensation or compensation increase (e.g., VA service connection for chronic pain), unable to fluently read or converse in English, no internet access.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

VA Greater Los Angeles Healthcare Center

Los Angeles, California, 90073, United States

Location

MeSH Terms

Conditions

Musculoskeletal PainChronic PainMusculoskeletal Diseases

Condition Hierarchy (Ancestors)

Muscular DiseasesPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
TREATMENT
Intervention Model
SINGLE GROUP
Model Details: Video teleconference delivered Emotional Awareness and Expression Therapy
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

September 2, 2020

First Posted

September 17, 2020

Study Start

August 15, 2020

Primary Completion

August 16, 2021

Study Completion

August 16, 2021

Last Updated

April 26, 2024

Record last verified: 2024-04

Data Sharing

IPD Sharing
Will not share

Locations